top of page

Changing the Future for Your Health

Our mission is to advance precision healthcare through generative & explainable AI—spanning diagnostics, treatment , and personalized medicine.

Brand logo AI Med Expert

Artificial Intelligence Expert SRL is a biomedical data science company pioneering AI-driven healthcare solutions.
Through our AIMedExpert brand, we develop advanced diagnostic and predictive tools—from oncology and mental health to spectroscopy-based metabolic syndrome monitoring. Leading AI development in four competitively won EU-funded research projects, our platforms combine Generative & Explainable AI with multimodal and multi-omics data analysis, Synthetic Data Generation, Digital Twins, and New Approach Methods. E.g. Our award-winning  non-invasive multi-cancer detection test achieving over 99% accuracy

Alexandru Floares, MD, PhD, CEO and Founder of Artificial Intelligence Expert SRL, pioneering AI-powered medical diagnostics and personalized precision medicine, leading clinical validation of machine learning cancer detection algorithms, directing Horizon Europe biomedical research consortia, advancing healthcare AI innovation, and establishing gold-standard protocols for AI-driven oncology and precision diagnostics in clinical practice

Alexandru Floares, MD,PhD

CEO and Founder

alexandru.floares@aie-op.com

Alexandru Floares, MD, PhD, founder and CEO of Artificial Intelligence Expert, is a leader in AI-powered medical diagnostics and therapy personalization. Since founding the AI Department at the Oncology Institute of Cluj-Napoca in 2000 and launching SAIA in 2004, he has set new industry standards, particularly in oncology. His work includes developing the first intelligent system for extracting mathematical models from biomedical data and leading significant research projects. Dr. Floares has presented his findings at prestigious institutions such as the NIH and the Vatican, published extensively, and received numerous awards. Since 2008, his collaboration with MD Anderson Cancer Center has led to revolutionary AI-enabled diagnostics for various cancers, achieving up to 100% accuracy and resulting in an international patent application.

Our team is led by our CEO, recognized as one of the 500 geniuses of the 21st century, with vast expertise in AI and medicine. We also have young, ambitious bioinformaticians and researchers specialized in multidisciplinary fields. Their combined talents drive our innovative approach to early cancer detection and revolutionizing research through the implementation of AI tools for researchers.

Our Team

Carmen Floares, MD, CoFounder and Chief Medical Officer at Artificial Intelligence Expert SRL, board-certified medical oncologist and clinical research pioneer advancing AI-powered cancer detection, precision oncology therapeutics, and machine learning biomarker discovery through multi-institutional clinical trials, EU-funded research programs, and personalized treatment protocols in translational medical science

Carmen Floares

CoFounder & Chief Medical Officer

Adrian Zety, Chief Project Officer and EU Research Innovation Director at Artificial Intelligence Expert SRL, managing Horizon Europe and multi-million euro EU-funded biomedical AI research consortia, overseeing clinical validation studies, biomedical informatics integration, machine learning healthcare platforms, and translational AI research programs across European healthcare networks and academic institutions

Adrian Zety

Chief Project Officer

Catalin Marginean, Chief Financial and Account Manager at Artificial Intelligence Expert SRL, managing EU grant administration, Horizon Europe project budgets, clinical research accounting, biomedical AI platform financing, healthcare innovation project funding, and financial operations for multi-institutional European research consortia in precision medicine and AI-driven diagnostics

Catalin Marginean

Account & Financial Manager

Sheraz Naseer, PhD, Chief Technology Officer at Artificial Intelligence Expert SRL, leading AI infrastructure development, machine learning platform architecture, deep learning model optimization, healthcare data integration systems, clinical AI deployment pipelines, and high-performance computing solutions for precision medicine diagnostics and biomedical research applications

Sheraz Naseer Ph.D

Chief Technology Officer

Maaz Mohsin, Data Scientist at Artificial Intelligence Expert SRL, developing machine learning models for cancer detection and biomedical AI diagnostics

Maaz Mohsin

Data Scientist

Lampros Androutsos, PhD, Lead Bioinformatics and AI Product Manager at Artificial Intelligence Expert SRL, pioneering multi-omics data analysis platforms, circulating microRNA biomarker discovery, next-generation sequencing (NGS) data interpretation, genomic machine learning algorithms, cancer microbiome research, and integrated bioinformatics solutions for personalized oncology and precision healthcare diagnostics

Lampros Androutsos

Product Manager

Larisa Petcu, Grant Manager and Research Proposal Specialist at Artificial Intelligence Expert SRL, expert in Horizon Europe, Romanian-funded research programs, and EU healthcare innovation funding, developing competitive grant proposals for clinical AI research, managing multi-institutional research consortia, coordinating biomedical innovation projects, and securing funding for precision medicine and cancer diagnostics initiatives

Larisa Petcu

Project Manager

Advisory Board

Our Advisory Board includes world-renowned cancer research and computing professors, as well as experienced leaders in business development and marketing. Their combined expertise drives our mission to revolutionize early cancer detection with advanced AI technologies.

George Calin, MD-PhD, Co-Director of RNA Interference and Non-coding RNA Research Center at MD Anderson Cancer Center, Houston, advising on AI-powered cancer detection, microRNA biomarker validation, RNA therapeutics discovery, precision oncology applications, and clinical translation of machine learning models in cancer diagnosis and personalized treatment strategies

George Calin,

MD-PhD

Co-Director of The RNA Interference and Non-coding RNA Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Florin Manolache, PhD, Director of Scientific Computing at Carnegie Mellon University, advising on high-performance computing architecture, advanced machine learning algorithms, deep learning optimization, computational biology applications, scalable AI infrastructure, and algorithmic innovation for biomedical research and healthcare AI systems

Florin Manolache, PhD

Director of Scientific Computing for MCS at Carnegie Mellon University

Antonio Ornelas-Soares, PhD, CEO of LUMABS, advising on biomedical innovation commercialization, AI-driven healthcare market strategy, precision medicine business development, clinical diagnostic platform scaling, healthcare technology partnerships, and translating AI research into clinical and commercial healthcare solutions

Antonio Ornelas-Soares, PhD

CEO of LUMABS

Ada Brzezicki, MD, MBA, Senior Business Development Manager at Partner International, advising on AI healthcare commercialization strategy, clinical diagnostic market expansion, healthcare technology partnerships, regulatory pathways for AI medical devices, and international business development for precision medicine platforms and AI-driven clinical innovations

Ada Brzezicki,

MD, MBA

Senior Business Development Manager at Partner International

Mihaela Rus, CEO of Vitrina Advertising, advising on digital marketing strategy for AI healthcare solutions, healthcare technology brand positioning, medical technology content marketing, biomedical innovation communications, and strategic brand development for precision medicine and AI-driven diagnostic platforms

Mihaela Rus

CEO Vitrina Advertising

bottom of page